Navigation Links
Boehringer Ingelheim Presents Progression-Free Survival Data for Investigational Afatinib and Nintedanib in Advanced NSCLC
Date:5/15/2013

which are types of enzymes measured to determine liver health[7] – as well as diarrhea (3% versus 1%) were observed in patients treated with nintedanib plus pemetrexed.2 Hypertension, bleeding, thrombosis, mucositis and neuropathy (greater than or equal to grade 3) were comparable between the two treatment arms.2 No increase in serious adverse events or grade five adverse events was observed in patients who received the combination of nintedanib plus pemetrexed.2

This study is part of the comprehensive LUME-Lung clinical trial program that is investigating nintedanib in different lung cancer treatment settings. Results from a second trial in the nintedanib LUME-Lung program will be presented on June 3 at ASCO.

About NSCLC and EGFR Mutations

NSCLC is the most common form of lung cancer, accounting for about 85 percent of all diagnoses.8 Between 10 and 15 percent of Caucasians and approximately 40 percent of Asians with NSCLC have EGFR mutations9 – 90 percent of which are the result of two mutations (Del19 or L858R).10

About Afatinib

Afatinib is an investigational, oral, once-daily irreversible ErbB Family Blocker that specifically inhibits epidermal growth factor receptor (EGFR or ErbB1), human epidermal receptor 2 (HER2 or ErbB2) and ErbB4. It is currently in Phase III clinical development in advanced NSCLC and head and neck cancer. The company has submitted applications requesting the review of afatinib for patients with EGFR mutation-positive advanced NSCLC to regulatory authorities in a number of countries and regions worldwide, including the U.S., E.U. and Asia.

Afatinib is not approved by the FDA; its safety and efficacy have not been established. 

About Nintedanib

Nintedanib (BIBF 1120) is an investigational orally-administered triple angiokinase inhibitor that targets three of the receptor
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation
2. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
3. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
4. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
5. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
6. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
7. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
8. Boehringer Ingelheim announces afatinib expanded access program (EAP) for patients with EGFR mutation-positive advanced NSCLC
9. Whistleblowers extraordinary efforts helped win $95 million settlement with Boehringer Ingelheim
10. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
11. Boehringer Ingelheim Announces Equine Research Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 2014 Heart Imaging Technologies LLC (HeartIT) ... provider of complete digital software and hardware imaging ... The licensed patents cover the use of zero ... images in a standard Internet web browser. ... its Subsidiaries will not challenge the validity or ...
(Date:9/30/2014)... Sept. 30, 2014 It is evident from the ... is not performing upto expectations due to the lack of ... with the intake of omega-3 fatty acids. Among omega-3 ingredient ... fish oil, attributed to the large vegetarian population in ... polyunsaturated fatty acid (PUFAs) ingredients is in growth stage of ...
(Date:9/30/2014)... BETHESDA, Md. , Sept. 30, 2014 ... "Company") (Nasdaq: CHDX ) today announced the ... ("Healthy Harmony") for $24.00 per share in cash.  Healthy ... (Group) Co., Ltd. ("Fosun") and Ms. Roberta Lipson ... previously announced merger agreement was adopted by Chindex,s stockholders ...
Breaking Medicine Technology:Omega-3 Polyunsaturated Fatty Acids (PUFAs) - An Indian Market Overview 2Chindex Completes Go-Private Transaction With Healthy Harmony Holdings, L.P. 2Chindex Completes Go-Private Transaction With Healthy Harmony Holdings, L.P. 3Chindex Completes Go-Private Transaction With Healthy Harmony Holdings, L.P. 4Chindex Completes Go-Private Transaction With Healthy Harmony Holdings, L.P. 5
... Development Plan Completed Successfully, DUBLIN, Ireland, July ... today announced that the Company recently met with,officials ... to discuss the,Company,s plans to develop AMR101 for ... is,proceeding to Phase 3 with AMR101 in hypertriglyceridemia., ...
... Stress the Importance to Patients of Passing a ... Follow- On Biologics Approval Pathway, ... developer of follow-on biologics and biopharmaceuticals, today,announced that Geoffrey Allan, ... Friday, July 25th, 2008 to discuss the,significant need for establishing ...
Cached Medicine Technology:Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3
(Date:9/30/2014)... valuable procedure by which to screen for the ... healthy Americans who do undergo this sometimes uncomfortable ... actually should. Gina Kruse of Massachusetts General ... endoscopists stick to the national guidelines more closely. ... General Internal Medicine , published by Springer. ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 MyServer2Go.com ... Arvixe as the Best VPS Hosting this year for ... well as affordable price. , MyServer2Go.com is a ... of VPS hosting services. And this announcement will help ... , According to MyServer2Go.com, Arvixe ( http://www.arvixe.com ) is ...
(Date:9/30/2014)... September 30, 2014 MyMobileUni seeks to ... NGO’s who have similar shared vision to transform individuals ... Honorary Advisor (MMU):, , ... 24/7 for all ages , to have ... empowerment , to promote equal access to ...
(Date:9/30/2014)... University of Eastern Finland shows that dietary polyunsaturated fatty ... The sources of polyunsaturated fatty acids include fish, vegetable ... Arteriosclerosis, Thrombosis & Vascular Biology , an esteemed journal ... not found an association between the consumption of saturated ... that the mere reduction of saturated fats from the ...
(Date:9/30/2014)... Doheny HealthDay Reporter , ... are given broad-spectrum antibiotics before the age of 2 ... during childhood, new research suggests. Broad-spectrum antibiotics target ... to the study. "It is a reason to ... you are picking," said lead researcher Dr. Charles Bailey, ...
Breaking Medicine News(10 mins):Health News:Americans undergo colonoscopies too often, study finds 2Health News:Arvixe Is Named Best VPS Hosting by MyServer2Go.com 2Health News:MyMobileUniversity Call to Public and Private Organisations, NGOs’ and Individuals: Catalyze Positive Social Change, Let’s Transform Individuals and Empower Communities 2Health News:MyMobileUniversity Call to Public and Private Organisations, NGOs’ and Individuals: Catalyze Positive Social Change, Let’s Transform Individuals and Empower Communities 3Health News:Dietary polyunsaturated fatty acids linked to smaller risk of coronary heart disease 2Health News:Antibiotic Use Before Age 2 Might Raise Obesity Risk, Study Says 2Health News:Antibiotic Use Before Age 2 Might Raise Obesity Risk, Study Says 3
... and patient embarrassment may prevent dermatologists, internists and ... to a report in the January issue of ... JAMA/Archives journals. However, dermatologists are significantly more likely ... screenings. Skin cancer is the most frequently ...
... , MONDAY, Jan. 17 (HealthDay News) -- Patients ... that can detect the deadly skin cancer at an early ... embarrassment prevents some people from having a doctor examine their ... journal Archives of Dermatology . People at high ...
... birth weight in First Nations (North American Indian) babies are ... that occur from 4 weeks to 1 year of age), ... Canadian Medical Association Journal ) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj100837.pdf ... as a child being born above the 90th percentile relative ...
... (HealthDay News) -- Cigarettes start to destroy a smoker,s ... that the habit causes immediate genetic damage and quickly ... reported here should serve as a stark warning to ... study author Stephen S. Hecht, from the Masonic Cancer ...
... DETROIT - Shoulder motion after rotator cuff surgery remains significantly ... a Henry Ford Hospital study. In a study that ... of motion of the arm bone in relation to the ... patients who had arthroscopic surgical repair of tendon tears and ...
... HealthDay Reporter , FRIDAY, Jan. 14 (HealthDay ... tend to befriend and date people who are also ... echoes previous research that found health behaviors, and their ... Tricia M. Leahey, an assistant professor of psychiatry and ...
Cached Medicine News:Health News:Clinicians cite time, patient embarrassment as barriers to performing skin cancer exams 2Health News:Thorough Exams a Must for Those at High Risk of Skin Cancer 2Health News:Thorough Exams a Must for Those at High Risk of Skin Cancer 3Health News:High birth weight in First Nations babies linked to a higher risk of postneonatal death 2Health News:Smoking Damages DNA Within Minutes, Research Shows 2Health News:Henry Ford Hospital study: Shoulder function not fully restored after surgery 2Health News:Overweight Young Adults Often Have Overweight Friends, Sweethearts 2Health News:Overweight Young Adults Often Have Overweight Friends, Sweethearts 3
... For use as a ... detecting IgG antibody to Toxoplasma ... to rubella virus (rubella IgG), ... IgG) and IgG antibody to ...
... The VITROS HBsAg assay is ... by the U.S. Food and ... in a random,access format on ... Intellicheck. Now you can run ...
... The Total PSA method for ... immunoassay module is an in vitro ... total prostate specific antigen (TPSA) in ... used as an aid in the ...
... based on sequential binding of HCG from ... for the *-chain of HCG) immobilized on ... the *-chain of HCG) conjugated to the ... chromogenic substrate is added and colors developed. ...
Medicine Products: